On May 4–5, 2026, ETAP‑LAB will take part in Swiss Biotech Day, one of Europe’s leading biotechnology events, held at the Congress Center Basel (Switzerland).
On this occasion, Nicolas Violle, CEO of ETAP‑LAB, will be attending to meet early‑stage biotech, pharma, and medtech companies and discuss the scientific and strategic challenges of preclinical drug development.
👉 Learn more about the event:
🔗 https://www.swissbiotech.org/event/swiss-biotech-day/
A key meeting point for the international biotech ecosystem
Bringing together several thousand participants from around the world, Swiss Biotech Day has become a major hub for innovation and partnering. The event fosters concrete discussions, scientific collaborations, and international partnerships among project leaders, CROs/CDMOs, industrial players, and investors, all focused on advancing innovative therapeutic programs toward the clinic.
For ETAP‑LAB, participation in Swiss Biotech Day is driven by a clear business objective: connect with project teams, understand their R&D challenges, and propose tailored preclinical support at critical stages of development.
Preclinical expertise dedicated to ambitious programs
ETAP‑LAB is an independent CRO with recognized expertise in in vitro and in vivo preclinical pharmacology, particularly in the fields of:
- Dermatology
- Cardiology
- Neurology, including CNS and stroke (ischemic and hemorrhagic)
Our mission is to support and accelerate drug candidate development by providing robust, translational models that generate reliable, decision‑enabling data throughout the preclinical phase.
A trusted partner built on rigor and proximity
With more than 35 years of experience, ETAP‑LAB is distinguished by:
- a high level of scientific rigor,
- full transparency throughout each project,
- strong responsiveness,
- and a close, collaborative client relationship, essential for building efficient and long‑term partnerships.
Meeting ETAP‑LAB at Swiss Biotech Day means engaging with a committed partner able to secure and streamline your preclinical development strategy.
📅 Schedule a meeting with ETAP‑LAB
ETAP‑LAB is registered on the official Swiss Biotech Day partnering platform.
👉 We invite you to book a one‑to‑one meeting with Nicolas Violle to discuss your projects and R&D challenges directly.
➡️ Schedule your meeting via the event’s partnering platform and meet us in Basel to move your preclinical programs forward together.
